ID   E2AK3_HUMAN             Reviewed;        1116 AA.
AC   Q9NZJ5; A0AVH1; A0AVH2; B2RCU9; O95846; Q53QY0; Q53SB1;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Eukaryotic translation initiation factor 2-alpha kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=PRKR-like endoplasmic reticulum kinase;
DE   AltName: Full=Pancreatic eIF2-alpha kinase;
DE            Short=HsPEK;
DE   Flags: Precursor;
GN   Name=EIF2AK3; Synonyms=PEK, PERK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANTS ARG-166 AND
RP   SER-704.
RC   TISSUE=Liver, Pancreas, and Testis;
RX   PubMed=10026192; DOI=10.1074/jbc.274.9.5723;
RA   Shi Y., An J., Liang J., Hayes S.E., Sandusky G.E., Stramm L.E.,
RA   Yang N.N.;
RT   "Characterization of a mutant pancreatic eIF-2alpha kinase, PEK, and
RT   co-localization with somatostatin in islet delta cells.";
RL   J. Biol. Chem. 274:5723-5730(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANTS ARG-166 AND
RP   SER-704.
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=10677345; DOI=10.1042/bj3460281;
RA   Sood R., Porter A.C., Ma K., Quilliam L.A., Wek R.C.;
RT   "Pancreatic eukaryotic initiation factor-2alpha kinase (PEK)
RT   homologues in humans, Drosophila melanogaster and Caenorhabditis
RT   elegans that mediate translational control in response to endoplasmic
RT   reticulum stress.";
RL   Biochem. J. 346:281-293(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT WRS GLN-588, AND VARIANT
RP   CYS-136.
RX   PubMed=10932183; DOI=10.1038/78085;
RA   Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M.,
RA   Julier C.;
RT   "EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is
RT   mutated in patients with Wolcott-Rallison syndrome.";
RL   Nat. Genet. 25:406-409(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-166 AND
RP   SER-704.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-715, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION AT TYR-619, AND DEPHOSPHORYLATION AT TYR-619.
RX   PubMed=22169477; DOI=10.1126/scisignal.2002329;
RA   Krishnan N., Fu C., Pappin D.J., Tonks N.K.;
RT   "H2s-induced sulfhydration of the phosphatase PTP1B and its role in
RT   the endoplasmic reticulum stress response.";
RL   Sci. Signal. 4:RA86-RA86(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1094, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   ADP-RIBOSYLATION BY PARP16.
RX   PubMed=23103912; DOI=10.1038/ncb2593;
RA   Jwa M., Chang P.;
RT   "PARP16 is a tail-anchored endoplasmic reticulum protein required for
RT   the PERK-and IRE1alpha-mediated unfolded protein response.";
RL   Nat. Cell Biol. 14:1223-1230(2012).
RN   [11]
RP   INTERACTION WITH TMEM33.
RX   PubMed=26268696; DOI=10.1007/s10549-015-3536-7;
RA   Sakabe I., Hu R., Jin L., Clarke R., Kasid U.N.;
RT   "TMEM33: a new stress-inducible endoplasmic reticulum transmembrane
RT   protein and modulator of the unfolded protein response signaling.";
RL   Breast Cancer Res. Treat. 153:285-297(2015).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-136; VAL-566 AND LEU-716.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Metabolic-stress sensing protein kinase that
CC       phosphorylates the alpha subunit of eukaryotic translation
CC       initiation factor 2 (eIF-2-alpha/EIF2S1) on 'Ser-52' during the
CC       unfolded protein response (UPR) and in response to low amino acid
CC       availability. Converts phosphorylated eIF-2-alpha/EIF2S1 either in
CC       a global protein synthesis inhibitor, leading to a reduced overall
CC       utilization of amino acids, or to a translation initiation
CC       activator of specific mRNAs, such as the transcriptional activator
CC       ATF4, and hence allowing ATF4-mediated reprogramming of amino acid
CC       biosynthetic gene expression to alleviate nutrient depletion.
CC       Serves as a critical effector of unfolded protein response (UPR)-
CC       induced G1 growth arrest due to the loss of cyclin-D1 (CCND1).
CC       Involved in control of mitochondrial morphology and function.
CC       {ECO:0000250|UniProtKB:Q9Z2B5}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Perturbation in protein folding in the
CC       endoplasmic reticulum (ER) promotes reversible dissociation from
CC       HSPA5/BIP and oligomerization, resulting in
CC       transautophosphorylation and kinase activity induction.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Forms dimers with HSPA5/BIP in resting cells.
CC       Oligomerizes in ER-stressed cells. Interacts with DNAJC3 and MFN2
CC       (By similarity). Interacts with TMEM33 (PubMed:26268696).
CC       {ECO:0000250|UniProtKB:Q9Z2B5, ECO:0000269|PubMed:26268696}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-766076, EBI-766076;
CC       P11021:HSPA5; NbExp=4; IntAct=EBI-766076, EBI-354921;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. A high level expression is seen in
CC       secretory tissues.
CC   -!- INDUCTION: By endoplasmic reticulum stress.
CC   -!- DOMAIN: The lumenal domain senses perturbations in protein folding
CC       in the ER, probably through reversible interaction with HSPA5/BIP.
CC       {ECO:0000250}.
CC   -!- PTM: Oligomerization of the N-terminal ER luminal domain by ER
CC       stress promotes PERK trans-autophosphorylation of the C-terminal
CC       cytoplasmic kinase domain at multiple residues including Thr-982
CC       on the kinase activation loop (By similarity). Autophosphorylated.
CC       Phosphorylated at Tyr-619 following endoplasmic reticulum stress,
CC       leading to activate its tyrosine-protein kinase activity.
CC       Dephosphorylated by PTPN1/TP1B, leading to inactivate its enzyme
CC       activity. {ECO:0000250, ECO:0000269|PubMed:22169477}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: ADP-ribosylated by PARP16 upon ER stress, which increases
CC       kinase activity.
CC   -!- DISEASE: Wolcott-Rallison syndrome (WRS) [MIM:226980]: A rare
CC       autosomal recessive disorder, characterized by permanent neonatal
CC       or early infancy insulin-dependent diabetes and, at a later age,
CC       epiphyseal dysplasia, osteoporosis, growth retardation and other
CC       multisystem manifestations, such as hepatic and renal
CC       dysfunctions, mental retardation and cardiovascular abnormalities.
CC       {ECO:0000269|PubMed:10932183}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. GCN2 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF110146; AAD19961.1; -; mRNA.
DR   EMBL; AF193339; AAF61199.1; -; mRNA.
DR   EMBL; AF284615; AAF91480.1; -; Genomic_DNA.
DR   EMBL; AF284604; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284605; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284606; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284607; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284608; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284609; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284610; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284611; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284612; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284613; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284614; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AK315287; BAG37696.1; -; mRNA.
DR   EMBL; AC062029; AAY14777.1; -; Genomic_DNA.
DR   EMBL; AC104134; AAY24331.1; -; Genomic_DNA.
DR   EMBL; BC126354; AAI26355.1; -; mRNA.
DR   EMBL; BC126356; AAI26357.1; -; mRNA.
DR   CCDS; CCDS33241.1; -.
DR   RefSeq; NP_004827.4; NM_004836.6.
DR   UniGene; Hs.591589; -.
DR   PDB; 4G31; X-ray; 2.28 A; A=588-1093.
DR   PDB; 4G34; X-ray; 2.70 A; A=588-1093.
DR   PDB; 4M7I; X-ray; 2.34 A; A=588-1093.
DR   PDB; 4X7H; X-ray; 2.00 A; A=575-1094.
DR   PDB; 4X7J; X-ray; 2.30 A; A=575-1094.
DR   PDB; 4X7K; X-ray; 1.80 A; A=575-1094.
DR   PDB; 4X7L; X-ray; 1.90 A; A=575-1094.
DR   PDB; 4X7N; X-ray; 2.35 A; A=575-1094.
DR   PDB; 4X7O; X-ray; 2.65 A; A=575-1094.
DR   PDB; 4YZS; X-ray; 3.14 A; A/B=104-403.
DR   PDB; 5SV7; X-ray; 3.21 A; A/B/C/D=95-420.
DR   PDBsum; 4G31; -.
DR   PDBsum; 4G34; -.
DR   PDBsum; 4M7I; -.
DR   PDBsum; 4X7H; -.
DR   PDBsum; 4X7J; -.
DR   PDBsum; 4X7K; -.
DR   PDBsum; 4X7L; -.
DR   PDBsum; 4X7N; -.
DR   PDBsum; 4X7O; -.
DR   PDBsum; 4YZS; -.
DR   PDBsum; 5SV7; -.
DR   ProteinModelPortal; Q9NZJ5; -.
DR   SMR; Q9NZJ5; -.
DR   BioGrid; 114840; 42.
DR   IntAct; Q9NZJ5; 8.
DR   STRING; 9606.ENSP00000307235; -.
DR   BindingDB; Q9NZJ5; -.
DR   ChEMBL; CHEMBL6030; -.
DR   GuidetoPHARMACOLOGY; 2017; -.
DR   iPTMnet; Q9NZJ5; -.
DR   PhosphoSitePlus; Q9NZJ5; -.
DR   BioMuta; EIF2AK3; -.
DR   DMDM; 296439367; -.
DR   EPD; Q9NZJ5; -.
DR   MaxQB; Q9NZJ5; -.
DR   PaxDb; Q9NZJ5; -.
DR   PeptideAtlas; Q9NZJ5; -.
DR   PRIDE; Q9NZJ5; -.
DR   Ensembl; ENST00000303236; ENSP00000307235; ENSG00000172071.
DR   GeneID; 9451; -.
DR   KEGG; hsa:9451; -.
DR   UCSC; uc002stc.5; human.
DR   CTD; 9451; -.
DR   DisGeNET; 9451; -.
DR   GeneCards; EIF2AK3; -.
DR   H-InvDB; HIX0023925; -.
DR   H-InvDB; HIX0030379; -.
DR   HGNC; HGNC:3255; EIF2AK3.
DR   HPA; CAB009204; -.
DR   HPA; HPA015737; -.
DR   MalaCards; EIF2AK3; -.
DR   MIM; 226980; phenotype.
DR   MIM; 604032; gene.
DR   neXtProt; NX_Q9NZJ5; -.
DR   OpenTargets; ENSG00000172071; -.
DR   Orphanet; 1667; Wolcott-Rallison syndrome.
DR   PharmGKB; PA27687; -.
DR   eggNOG; KOG1033; Eukaryota.
DR   eggNOG; ENOG410XS0B; LUCA.
DR   GeneTree; ENSGT00530000062984; -.
DR   HOVERGEN; HBG051431; -.
DR   InParanoid; Q9NZJ5; -.
DR   KO; K08860; -.
DR   OMA; KWKPLIH; -.
DR   OrthoDB; EOG091G01X1; -.
DR   PhylomeDB; Q9NZJ5; -.
DR   TreeFam; TF101511; -.
DR   Reactome; R-HSA-381042; PERK regulates gene expression.
DR   SignaLink; Q9NZJ5; -.
DR   SIGNOR; Q9NZJ5; -.
DR   ChiTaRS; EIF2AK3; human.
DR   GeneWiki; EIF2AK3; -.
DR   GenomeRNAi; 9451; -.
DR   PRO; PR:Q9NZJ5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000172071; -.
DR   CleanEx; HS_EIF2AK3; -.
DR   ExpressionAtlas; Q9NZJ5; baseline and differential.
DR   Genevisible; Q9NZJ5; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IDA:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IMP:UniProtKB.
DR   GO; GO:0070417; P:cellular response to cold; IMP:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0002063; P:chondrocyte development; ISS:UniProtKB.
DR   GO; GO:0036492; P:eiF2alpha phosphorylation in response to endoplasmic reticulum stress; IMP:UniProtKB.
DR   GO; GO:0031018; P:endocrine pancreas development; IMP:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB.
DR   GO; GO:0006983; P:ER overload response; IDA:UniProtKB.
DR   GO; GO:0030073; P:insulin secretion; ISS:UniProtKB.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031642; P:negative regulation of myelination; ISS:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; TAS:UniProtKB.
DR   GO; GO:0032057; P:negative regulation of translational initiation in response to stress; TAS:UniProtKB.
DR   GO; GO:0001503; P:ossification; IMP:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0060734; P:regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation; ISS:UniProtKB.
DR   GO; GO:1902235; P:regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010998; P:regulation of translational initiation by eIF2 alpha phosphorylation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL.
DR   GO; GO:1990737; P:response to manganese-induced endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF50998; SSF50998; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; ATP-binding; Complete proteome;
KW   Diabetes mellitus; Disease mutation; Endoplasmic reticulum;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Signal; Stress response; Transferase; Translation regulation;
KW   Transmembrane; Transmembrane helix; Unfolded protein response.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1116       Eukaryotic translation initiation factor
FT                                2-alpha kinase 3.
FT                                /FTId=PRO_0000024322.
FT   TOPO_DOM     30    514       Lumenal. {ECO:0000255}.
FT   TRANSMEM    515    535       Helical. {ECO:0000255}.
FT   TOPO_DOM    536   1116       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      593   1077       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     599    607       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     49     52       Poly-Ala.
FT   ACT_SITE    937    937       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     622    622       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     619    619       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:22169477}.
FT   MOD_RES     715    715       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     982    982       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z2B5}.
FT   MOD_RES    1094   1094       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   CARBOHYD    258    258       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     136    136       S -> C (in dbSNP:rs867529).
FT                                {ECO:0000269|PubMed:10932183,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_011409.
FT   VARIANT     166    166       Q -> R (in dbSNP:rs13045).
FT                                {ECO:0000269|PubMed:10026192,
FT                                ECO:0000269|PubMed:10677345,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_011410.
FT   VARIANT     566    566       D -> V (in dbSNP:rs55791823).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040477.
FT   VARIANT     588    588       R -> Q (in WRS; dbSNP:rs121908569).
FT                                {ECO:0000269|PubMed:10932183}.
FT                                /FTId=VAR_011408.
FT   VARIANT     704    704       A -> S (in dbSNP:rs1805165).
FT                                {ECO:0000269|PubMed:10026192,
FT                                ECO:0000269|PubMed:10677345,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_011411.
FT   VARIANT     716    716       P -> L (in dbSNP:rs55861585).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040478.
FT   CONFLICT     14     14       Missing (in Ref. 1; AAD19961, 2;
FT                                AAF61199, 3; AAF91480, 4; BAG37696 and 6;
FT                                AAI26357). {ECO:0000305}.
FT   CONFLICT    490    490       N -> H (in Ref. 2; AAF61199).
FT                                {ECO:0000305}.
FT   STRAND      105    110       {ECO:0000244|PDB:4YZS}.
FT   STRAND      113    118       {ECO:0000244|PDB:4YZS}.
FT   TURN        120    123       {ECO:0000244|PDB:4YZS}.
FT   STRAND      126    131       {ECO:0000244|PDB:4YZS}.
FT   STRAND      137    139       {ECO:0000244|PDB:4YZS}.
FT   STRAND      152    158       {ECO:0000244|PDB:4YZS}.
FT   STRAND      161    164       {ECO:0000244|PDB:4YZS}.
FT   STRAND      166    169       {ECO:0000244|PDB:4YZS}.
FT   STRAND      171    173       {ECO:0000244|PDB:4YZS}.
FT   HELIX       178    182       {ECO:0000244|PDB:4YZS}.
FT   STRAND      193    204       {ECO:0000244|PDB:4YZS}.
FT   STRAND      207    209       {ECO:0000244|PDB:4YZS}.
FT   STRAND      215    217       {ECO:0000244|PDB:4YZS}.
FT   STRAND      220    222       {ECO:0000244|PDB:4YZS}.
FT   STRAND      237    248       {ECO:0000244|PDB:4YZS}.
FT   TURN        250    252       {ECO:0000244|PDB:4YZS}.
FT   STRAND      255    267       {ECO:0000244|PDB:4YZS}.
FT   STRAND      308    310       {ECO:0000244|PDB:4YZS}.
FT   TURN        314    317       {ECO:0000244|PDB:4YZS}.
FT   STRAND      321    323       {ECO:0000244|PDB:4YZS}.
FT   TURN        324    326       {ECO:0000244|PDB:4YZS}.
FT   STRAND      339    346       {ECO:0000244|PDB:4YZS}.
FT   STRAND      349    352       {ECO:0000244|PDB:4YZS}.
FT   HELIX       375    383       {ECO:0000244|PDB:4YZS}.
FT   STRAND      387    390       {ECO:0000244|PDB:4YZS}.
FT   STRAND      392    398       {ECO:0000244|PDB:4YZS}.
FT   HELIX       588    592       {ECO:0000244|PDB:4X7K}.
FT   STRAND      593    602       {ECO:0000244|PDB:4X7K}.
FT   STRAND      605    612       {ECO:0000244|PDB:4X7K}.
FT   TURN        613    615       {ECO:0000244|PDB:4X7K}.
FT   STRAND      618    625       {ECO:0000244|PDB:4X7K}.
FT   HELIX       630    644       {ECO:0000244|PDB:4X7K}.
FT   STRAND      654    660       {ECO:0000244|PDB:4X7K}.
FT   STRAND      883    889       {ECO:0000244|PDB:4X7K}.
FT   HELIX       896    901       {ECO:0000244|PDB:4X7K}.
FT   HELIX       906    908       {ECO:0000244|PDB:4X7K}.
FT   HELIX       911    930       {ECO:0000244|PDB:4X7K}.
FT   HELIX       940    942       {ECO:0000244|PDB:4X7K}.
FT   STRAND      943    945       {ECO:0000244|PDB:4X7K}.
FT   STRAND      951    953       {ECO:0000244|PDB:4X7K}.
FT   HELIX       993    996       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1004   1018       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1024   1035       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1041   1046       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1048   1057       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1062   1064       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1068   1072       {ECO:0000244|PDB:4X7K}.
FT   HELIX      1075   1077       {ECO:0000244|PDB:4X7K}.
SQ   SEQUENCE   1116 AA;  125216 MW;  95FEB5DAE8D3D452 CRC64;
     MERAISPGLL VRALLLLLLL LGLAARTVAA GRARGLPAPT AEAAFGLGAA AAPTSATRVP
     AAGAVAAAEV TVEDAEALPA AAGEQEPRGP EPDDETELRP RGRSLVIIST LDGRIAALDP
     ENHGKKQWDL DVGSGSLVSS SLSKPEVFGN KMIIPSLDGA LFQWDQDRES METVPFTVES
     LLESSYKFGD DVVLVGGKSL TTYGLSAYSG KVRYICSALG CRQWDSDEME QEEDILLLQR
     TQKTVRAVGP RSGNEKWNFS VGHFELRYIP DMETRAGFIE STFKPNENTE ESKIISDVEE
     QEAAIMDIVI KVSVADWKVM AFSKKGGHLE WEYQFCTPIA SAWLLKDGKV IPISLFDDTS
     YTSNDDVLED EEDIVEAARG ATENSVYLGM YRGQLYLQSS VRISEKFPSS PKALESVTNE
     NAIIPLPTIK WKPLIHSPSR TPVLVGSDEF DKCLSNDKFS HEEYSNGALS ILQYPYDNGY
     YLPYYKRERN KRSTQITVRF LDNPHYNKNI RKKDPVLLLH WWKEIVATIL FCIIATTFIV
     RRLFHPHPHR QRKESETQCQ TENKYDSVSG EANDSSWNDI KNSGYISRYL TDFEPIQCLG
     RGGFGVVFEA KNKVDDCNYA IKRIRLPNRE LAREKVMREV KALAKLEHPG IVRYFNAWLE
     APPEKWQEKM DEIWLKDEST DWPLSSPSPM DAPSVKIRRM DPFATKEHIE IIAPSPQRSR
     SFSVGISCDQ TSSSESQFSP LEFSGMDHED ISESVDAAYN LQDSCLTDCD VEDGTMDGND
     EGHSFELCPS EASPYVRSRE RTSSSIVFED SGCDNASSKE EPKTNRLHIG NHCANKLTAF
     KPTSSKSSSE ATLSISPPRP TTLSLDLTKN TTEKLQPSSP KVYLYIQMQL CRKENLKDWM
     NGRCTIEERE RSVCLHIFLQ IAEAVEFLHS KGLMHRDLKP SNIFFTMDDV VKVGDFGLVT
     AMDQDEEEQT VLTPMPAYAR HTGQVGTKLY MSPEQIHGNS YSHKVDIFSL GLILFELLYP
     FSTQMERVRT LTDVRNLKFP PLFTQKYPCE YVMVQDMLSP SPMERPEAIN IIENAVFEDL
     DFPGKTVLRQ RSRSLSSSGT KHSRQSNNSH SPLPSN
//
